TY  - GEN
AU  - Mazur,Wojciech
AU  - Kaluza,Grzegorz L
AU  - Sapp,Shelly
AU  - Balog,Craig
AU  - Topol,Eric J
AU  - Mark,Daniel B
AU  - Ellis,Stephen G
AU  - Kereiakes,Dean J
AU  - Lincoff,A Michael
AU  - Kleiman,Neal S
TI  - Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists
SN  - 1097-6744
PY  - 2002///0408
KW  - Abciximab
KW  - Antibodies, Monoclonal
KW  - economics
KW  - Coronary Disease
KW  - Female
KW  - Hospital Costs
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - etiology
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Risk Assessment
KW  - Stents
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1067/mhj.2002.121519
ER  -